![](/img/cover-not-exists.png)
OP0142 Masking CD94/NKG2A using a novel therapeutic MAB results in significant suppression of IL-6 levels and reduced osteoclast formation in rheumatoid arthritis ex vivo cultures
Söderström, K., Sundström, Y., Berg, L., Schepis, D., Galsgaard, E.D., Klareskog, L., Wagtmann, N.Volume:
71
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2012-eular.1825
Date:
June, 2013
File:
PDF, 62 KB
english, 2013